Correction to: Signal Transduction and Targeted Therapy https://doi.org/10.1038/s41392-024-01914-0, published online 08 August 2024
In the process of collating the raw data, the authors noticed one inadvertent mistake in supplementary figure 9f after online publication of the article1. The β-actin in supplementary figure 9d was repeatedly inserted as β-actin (upper) in supplementary figure 9f. The correct data and corresponding original image are provided as follows. This correction does not affect the key findings (the existing published results or the discussion). The original article has been corrected.
Supplementary Fig. 9f. BHMT1 protein levels in mouse hepatocytes administrated by different doses of AAV-BHMT1(WT) or AAV-BHMT1(T45A) for 48 h.
In the self-check after publication, several mismatches between the blots presented in the figures and the original uncropped blots were also identified.
In Fig. 5b, the original WB image was chosen from another experiment performed in the same condition, causing mismatch. The above is the matched original WB image. The previously mismatched and newly matched images represented the different experiments performed in the same condition.
In Fig. 5l, the original WB image was chosen as another image obtained from the same membrane but with different exposure, causing mismatch. The above is the matched original WB image. The previously mismatched and newly matched images represented the same experiment.
In Supplementary Fig. 5a, the previous original WB image was chosen from another experiment performed in the same condition, causing mismatch. The previously mismatched and newly matched images represented the different experiments performed in the same condition.
In Supplementary Fig. 9d, the original WB image was chosen from another experiment performed in the same condition, causing mismatch. The above is the matched original WB image. The previously mismatched and newly matched images represented the different experiments performed in the same condition.
In Supplementary Fig. 18c, the original WB image was chosen from another experiment performed in the same condition, causing mismatch. The above is the matched original WB image. The previously mismatched and newly matched images represented the different experiments performed in the same condition.
These corrections have no effect on the description and meaning of each figure and overall conclusion.
The original article has been corrected.
Reference
Yan, H. et al. Ribosomal modification protein rimK-like family member A activates betaine-homocysteine S-methyltransferase 1 to ameliorate hepatic steatosis. Signal Transduct Target Ther 9, 214, https://doi.org/10.1038/s41392-024-01914-0 (2024).
Author information
Authors and Affiliations
Corresponding authors
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Yan, H., Liu, W., Xiang, R. et al. Correction: Ribosomal modification protein rimK-like family member A activates betaine-homocysteine S-methyltransferase 1 to ameliorate hepatic steatosis. Sig Transduct Target Ther 9, 360 (2024). https://doi.org/10.1038/s41392-024-02054-1
Published:
DOI: https://doi.org/10.1038/s41392-024-02054-1
